miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume 33, Issue 7, Pages 1294-1301
Publisher
Oxford University Press (OUP)
Online
2012-05-20
DOI
10.1093/carcin/bgs179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p63-microRNA feedback in keratinocyte senescence
- (2012) P. Rivetti di Val Cervo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemia
- (2011) J. Tomic et al. BLOOD
- The prognostic significance of TP53 mutations in Chinese patients with chronic lymphocytic leukemia is independent of del(17p13)
- (2010) Hua-Jie Dong et al. ANNALS OF HEMATOLOGY
- microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival
- (2010) S. Rossi et al. BLOOD
- Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists
- (2010) Brian J. Lestini et al. CANCER BIOLOGY & THERAPY
- Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia
- (2010) Olga Grzybowska-Izydorczyk et al. EUROPEAN JOURNAL OF CANCER
- The High Throughput Screening of Direct Regulatory microRNA and Their Target Genes*
- (2010) Zhi-Yun GUO et al. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS
- CLL and activated NF- B: living partnership
- (2008) E. Hertlein et al. BLOOD
- Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
- (2008) C. Pepper et al. BLOOD
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- Mcl-1: A Gateway to TRAIL Sensitization
- (2008) S.-H. Kim et al. CANCER RESEARCH
- Expanding Circle of Inhibition: Small-Molecule Inhibitors of Bcl-2 as Anticancer Cell and Antiangiogenic Agents
- (2008) Benjamin D. Zeitlin et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-181b negatively regulates activation-induced cytidine deaminase in B cells
- (2008) Virginia G. de Yébenes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
- (2008) Désirée Bonci et al. NATURE MEDICINE
- miR-34a repression of SIRT1 regulates apoptosis
- (2008) M. Yamakuchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells
- (2007) P. G. Longo et al. BLOOD
- Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia
- (2007) Wei Xu et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation